The Silent Crisis
The Reality of Childhood Cancer
1 in 263 children in the US will be diagnosed with cancer. Yet the systems built to save them are decades behind. This is the crisis most people never see.
Why This Matters
“She wasn't just fighting for herself. She was fighting so we'd finally pay attention to what's been broken all along.”
Kyra endured a battle for >3 years that was marked by relentless pain, suffering and trauma, subjected to treatments that have barely changed in >40 years, 1000s of rounds of chemotherapy, radiation, countless needles, and major surgeries including leg transplants that no child should ever have to face.
Her final act of courage was donating her body to medical science so that research could move faster for the next child. Today, while we sit here, her cancer is still being studied in laboratories. Her tumor samples are actively fueling the research that may one day save another child's life.
The Numbers
4% Is All They Get
Childhood cancer is the #1 disease killer of children, yet receives only 4% of federal research funding. This isn't neglect, it's systemic market failure.
$200M
Pediatric Cancer Research
Federal funding annually
$4.8B
Adult Cancer Research
Federal funding annually
We treat 2026 children with 1970s operating systems. Children are given drugs designed for adult biology, suffering medieval side effects while the market ignores them.
Treatment Options
8 Drugs in 45 Years
Only 8 drugs have been approved specifically for pediatric cancer since 1979. For adults, roughly 12 new drugs are approved every single year.
Pediatric Cancer — 8 drugs since 1979
Adult Cancer — ~12 new drugs approved per year
Showing ~4 years of adult cancer drug approvals for comparison
System Failure
The Double Disadvantage
Within the limited 4% of the cancer budget allocated to children, rare cancers like Ewing Sarcoma receive less than 1%. Survival rates have been stuck at 20–30% for decades.
Too Pediatric
Limited patient population means low pharmaceutical ROI. With fewer cases, the profit motive that drives drug development simply doesn't exist for children's cancers.
4%
of federal research funding
Too Rare
Even within the 4% allocated to children, rare cancers like Ewing Sarcoma receive less than 1%. About 600 sarcoma cases are diagnosed annually, too "small" for commercial pharma interest.
<1%
of pediatric cancer funding
Too Complex
Unique biology requires specialized research infrastructure that doesn't exist at scale. Children are not small adults. Their cancers behave differently and demand different solutions.
~600
sarcoma cases annually in the US
Kyra faced this double disadvantage.
Her cancer was both rare and pediatric, trapped in a funding desert. The science exists to help children like her. What's missing is the infrastructure to bridge discovery to treatment.
The Bottleneck
The Valley of Death
Breakthroughs exist in labs right now, but they lack the "Infrastructure Capital" to become clinical trials. A $10 million gap between academic discovery and clinical trials means most cures die here.
Academic Discoveries
Preclinical Studies
The Valley of Death
$10M
funding gap · 97% of discoveries lost here
Clinical Trials
Cure
Our mission:
Fund the Phase 1 toxicity studies and translational research that commercial pharma won't touch. Bridge the valley. Turn lab discoveries into clinical trials. Save lives.
Average delay from lab to trial: 16 years · Data: NIH 2024
The True Cost
70 Years Stolen
Investing in a child preserves 70 years of human potential compared to just 15 in adults. It's the ultimate return on future innovation and impact.
4.7x
more years of life preserved by saving a child
25:1 — Yet funding flows to adult cancers at a 25:1 ratio. This is the ultimate market inefficiency.
Beyond Medical Bills
Financial Toxicity
Cancer doesn't just attack the child, it devastates the entire family structure. The lifetime financial burden on families can exceed $833K.
95%
Job Impact Rate
of families report at least one parent reducing hours, taking unpaid leave, or leaving their job entirely.
$833K
Lifetime Family Cost
Including medical bills, lost wages, travel, lodging, and uncovered expenses over the treatment journey.
60%
Relationship Breakdown
of marriages face extraordinary strain, with severe relationship challenges during and after treatment.
1 in 3
Housing Crisis
families report housing instability, foreclosure, or bankruptcy during their child's cancer journey.
The ROI of Survival
We don't just fund research. We rebuild the support systems that commercial markets abandoned—because whole family care is part of the cure.
A Path Forward
What It Takes to Fix This
Kyra's Hope Foundation sits at the rare intersection of lived experience, scientific rigor, and modern technology.
Cure
Unlocking Discovery
Engineering breakthroughs in Ewing Sarcoma and multi-rare cancer treatments: CAR-T immunotherapy for solid tumors, AI-targeted protein degradation, and precision genetic mapping for every child.
Care
Supporting Survival
"Care Kits" for families: direct financial intervention to relieve economic toxicity and job instability. Meals, transport, lodging, and emotional resources that address the full crisis.
Community
Sharing the Burden
Grassroots infrastructure to share the burden: sibling programs, school advocacy networks, sustained connection that replaces fragmented, short-term sympathy with lasting support.
Your Impact
What Your Gift Makes Possible
Every contribution builds the infrastructure that turns “incurable” into “history.”
$10K
Precision Mapping
Genetic sequencing for 4 children to find targeted biological treatments.
$50K
Research Catalyst
6 months of specialized AI-lab staffing to accelerate Ewing Sarcoma research.
$150K
Trial Launcher
Full seed-funding for a Phase I clinical trial pilot program.
$5M+
Immunotherapy Study
Fund a complete immunotherapy CAR-T cell study to engineer immune cells that target pediatric solid tumors like Ewing Sarcoma.
Join the Fight
Kyra Is Still Fighting. You Can Too.
Her tumor samples are still being studied in laboratories. Her spirit lives in every family we support. Every dollar moves us closer to a world where no child fights cancer with outdated weapons.